- Cognitive engagement may slow clinical progression and brain atrophy in Huntington's disease
- CRISPR/Cas9-induced double-strand breaks in the huntingtin locus lead to CAG repeat contraction through DNA end resection and homology-mediated repair
- Evidence-Based Review on Symptomatic Management of Huntington's Disease
- Intrathecal baclofen pump for severe hypertonia in a patient with juvenile Huntington's disease: illustrative case
- beta-Blocker Use and Delayed Onset and Progression of Huntington Disease
- Protective Effects of Antcin H Isolated from Antrodia cinnamomea Against Neuroinflammation in Huntington's Disease via NLRP3 Inflammasome Inhibition
- Bioinformatics and Machine Learning-Based Identification of Critical Biomarkers and Immune Infiltration in Venous Thromboembolism
- C. elegans huntingtin, htt-1, promotes robust autophagy induction and survival under stress conditions
- How many people have a Huntington's Disease expansion: A population-based prevalence study in Northern Scotland
- Unveiling the structural proteome of an Alzheimer's disease rat brain model
- A tool to automate assessment of regional brain atrophy in mouse models of neurodegenerative disease
- Shifting focus from ideality to reality: a qualitative study on how quality of life is defined by premanifest and manifest Huntington's disease gene expansion carriers
- Brain-derived neurotrophic factor plays with TRiC: focus on synaptic dysfunction in Huntington's disease
- Emerging biophysical techniques for probing synaptic transmission in neurodegenerative disorders
- Unveiling biomarker detection in Alzheimer's disease: a computational approach to microarray analysis
- Insights into RNA-mediated pathology in new mouse models of Huntington's disease
- Corrigendum: An automatic measure for speech intelligibility in dysarthrias-validation across multiple languages and neurological disorders
- Roscovitine, a CDK Inhibitor, Reduced Neuronal Toxicity of mHTT by Targeting HTT Phosphorylation at S1181 and S1201 In Vitro
- Advancements in Targeting Ion Channels for the Treatment of Neurodegenerative Diseases
- Erucin, a Natural Isothiocyanate, Prevents Polyglutamine-Induced Toxicity in <em>Caenorhabditis elegans</em> via <em>aak-2</em>/AMPK and <em>daf-16</em>/FOXO Signaling
- Co-Aggregation of TDP-43 with Other Pathogenic Proteins and Their Co-Pathologies in Neurodegenerative Diseases
- Exosome Cargo in Neurodegenerative Diseases: Leveraging Their Intercellular Communication Capabilities for Biomarker Discovery and Therapeutic Delivery
- Exploring the Connection Between Nanomaterials and Neurodegenerative Disorders
- Quantitative and Computational Spinal Imaging in Neurodegenerative Conditions and Acquired Spinal Disorders: Academic Advances and Clinical Prospects
- Small molecule modulation of p75(NTR) engages the autophagy-lysosomal pathway and reduces huntingtin aggregates in cellular and mouse models of Huntington's disease
- Copper homeostasis and neurodegenerative diseases
- Calcium bridges built by mitochondria-associated endoplasmic reticulum membranes: potential targets for neural repair in neurological diseases
- Global analysis of endogenous protein disorder in cells
- Insights into the causes and consequences of DNA repeat expansions from 700,000 biobank participants
- Exploring the role of vault complex in the nervous system: a literature review
- Neuroacanthocytosis: Case report and neuroimaging findings
- Striatum-enriched protein, arginase 2 localizes to medium spiny neurons and controls striatal metabolic profile
- Purinergic-associated immune responses in neurodegenerative diseases
- Reprogrammed human lateral ganglionic eminence precursors generate striatal neurons and restore motor function in a rat model of Huntington's disease
- Saffron and its major constituents against neurodegenerative diseases: A mechanistic review
- Unknown roles of tau pathology in neurological disorders. Challenges and new perspectives
- Critical role of hydrogen sulfide in the management of neurodegenerative disease
- Damage of the Phospholipid Bilayer by Aβ42 at Physiologically Relevant Peptide Concentrations
- Myelin Lipid Alterations in Neurodegenerative Diseases: Landscape and Pathogenic Implications
- Suppression of Huntington's Disease Somatic Instability by Transcriptional Repression and Direct CAG Repeat Binding
- F2,6BP restores mitochondrial genome integrity in Huntington's Disease
- Exploration of the Role of Vitamins in Preventing Neurodegenerative Diseases: Comprehensive Review on Preclinical and Clinical Findings
- Interplay between Sex and Disease Burden in Huntington's Disease: Clinical and Neuroimaging Perspectives
- Huntingtin CAG repeat size variations below the Huntington's disease threshold: associations with depression, anxiety and basal ganglia structure
- The Impact of Aging on Neurological Diseases in the Elderly: Molecular Mechanisms and Therapeutic Perspectives
- Correction: Huntington Disease Health Related Quality of Life, Function and Well Being: The Patient's Perspective
- Exploring the role of Cdk5 on striatal synaptic plasticity in a 3-NP-induced model of early stages of Huntington's disease
- Data-driven Huntington's disease progression modelling and estimation of societal cost in the UK
- More than just a number: the gut microbiota and brain function across the extremes of life
- Copper homeostasis and cuproptosis in central nervous system diseases
- Apathy and Functional Status in Early-Stage Huntington's Disease
- Mitochondrial DAMPs: Key Mediators in Neuroinflammation and Neurodegenerative Disease Pathogenesis
- Break-up and recovery of harmony between direct and indirect pathways in the basal ganglia: Huntington's disease and treatment
- Preventing acute neurotoxicity of CNS therapeutic oligonucleotides with the addition of Ca<sup>2+</sup> and Mg<sup>2+</sup> in the formulation
- Nanopore Identification of Polyglutamine Length via Cross-Slit Sensing
- A special focus on polyadenylation and alternative polyadenylation in neurodegenerative diseases: A systematic review
- Comprehensive Analysis of the Gene Expression Profiles of Rat Brain Tissues under Environmental Exposure to Nicotine
- Fueling neurodegeneration: metabolic insights into microglia functions
- Visual training induced occipital fast sleep spindle clustering in humans revealed by full-night HD-EEG recordings
- New MiniPromoter Ple389 (ADORA2A) drives selective expression in medium spiny neurons in mice and non-human primates
- Pathophysiological role of high mobility group box-1 signaling in neurodegenerative diseases
- Neurofilament light chain: a biomarker at the crossroads of clarity and confusion for gene-directed therapies
- Efficacy and Safety of Tetrabenazine in Reducing Chorea and Improving Motor Function in Individuals With Huntington's Disease: A Systematic Review
- Developmental and physiological impacts of pathogenic human huntingtin protein in the nervous system
- Progress in mechanism of pain associated with neurodegenerative diseases
- Lutein, a versatile carotenoid: Insight on neuroprotective potential and recent advances
- Quantitative proteomic analysis using a mouse model of Lewy body dementia induced by α-synuclein preformed fibrils injection
- Abnormal outer and inner retina in a mouse model of Huntington's disease with age
- Application of mesenchymal stem cells for neurodegenerative diseases therapy discovery
- Exploring lncRNA expression in follicular fluid exosomes of patients with obesity and polycystic ovary syndrome based on high-throughput sequencing technology
- Modulation of SNARE-dependent exocytosis in astrocytes improves neuropathology in Huntington's disease
- Mitochondrial dysfunction as a therapeutic strategy for neurodegenerative diseases: Current Insights and Future Directions
- The potential therapeutic strategy in combating neurodegenerative diseases: Focusing on natural products
- Decoding Nucleotide Repeat Expansion Diseases: Novel Insights from <em>Drosophila melanogaster</em> Studies
- Early Diagnosis of Huntington Disease: Insights from Magnetic Resonance Spectroscopy-A Systematic Review
- CK and LRRK2 Involvement in Neurodegenerative Diseases
- Neuroinflammatory Proteins in Huntington's Disease: Insights into Mechanisms, Diagnosis, and Therapeutic Implications
- Regulation of <em>HTT</em> mRNA Biogenesis: The Norm and Pathology
- A Case of Late-Onset De Novo Huntington's Disease Diagnosed via (18)F-FDG PET
- The Two Faces of HDAC3: Neuroinflammation in Disease and Neuroprotection in Recovery
- Iron Homeostasis and Neurodegeneration in the Aging Brain: Insight into Ferroptosis Pathways
- Evaluating the web-based 'Partner in Balance' program for informal caregivers of people with Huntington's disease: A pilot study
- Chorein deficiency promotes ferroptosis
- Performance Comparison between Deep Neural Network and Machine Learning based Classifiers for Huntington Disease Prediction from Human DNA Sequence
- New perspective on central nervous system disorders: focus on mass spectrometry imaging
- Pathological tau alters head direction signaling and induces spatial disorientation
- Mental Tasks Induce Common Modulations of Oscillations in Cortex and Spinal Cord
- The therapeutic potential of glycyrrhizic acid and its metabolites in neurodegenerative diseases: Evidence from animal models
- Correction of RBFOX1 deficit rescues Huntington's disease mis-splicing and pathology
- Accelerated Simulations Reveal Physicochemical Factors Governing Stability and Composition of RNA Clusters
- Restoring Compromised Cl<sup>-</sup> in D2 Neurons of a HD Mouse Model Rescues Motor Disability
- UBE3A: Bridging the gap between neurodevelopment, neural function, and neurodegenerative woes
- Direct observation of secondary nucleation in huntingtin amyloid formation by High-Speed Atomic Force Microscopy
- Therapeutic potentials of cannabidiol: Focus on the Nrf2 signaling pathway
- Mitochondrial dysfunction and inflammasome activation in neurodegenerative diseases: Mechanisms and therapeutic implications
- The cGAS-STING pathway drives neuroinflammation and neurodegeneration via cellular and molecular mechanisms in neurodegenerative diseases
- F2,6BP restores mitochondrial genome integrity in Huntingtons Disease
- Recent pharmacological insights on abating toxic protein species burden in neurological disorders: Emphasis on 26S proteasome activation
- Suppression of Huntington's Disease Somatic Instability by Transcriptional Repression and Direct CAG Repeat Binding
- On the neural substrates of mind wandering and dynamic thought: A drug and brain stimulation study
RSS Feed – Literature
HDinHD > RSS Feed – Literature
